🔎 Trials Near Me

Akèy › Migrèn › Illinois › Chicago

Etid klinik pou Migrèn nan Chicago, IL

4 etid pou Migrèn ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

Ap rekriteFaz 3
  • Chicago Headache Center & Research Institute, Chicago
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT04743141

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Ap rekriteFaz 3
  • Chicago Headache Center & Research Institute, Chicago
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT04649242

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Ap rekriteFaz 3
  • Chicago Headache Center & Research Institute /ID# 248625, Chicago
Laj 6 a 17 · Tout sèks · Mizajou Sep 14, 2026 · NCT05125302

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

Ap rekriteFaz 3
  • Cedar Crosse Research Center, Chicago
  • Chicago Headache Center & Research Institute, Chicago
Laj 18 a 75 · Tout sèks · Mizajou Aug 20, 2026 · NCT07645924

Etid Migrèn nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.